Metro Creative Connection

Editorial Videos

FDA Approves Sleep Apnea Device

Inspire Medical Systems, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Inspire Upper Airway Stimulation (UAS) therapy for use in a subset of patients with moderate to severe Obstructive Sleep Apnea (OSA) who are unable to use Continuous Positive Airway Pressure (CPAP). Inspire therapy is a fully implanted neurostimulation device, the first of its kind for sleep apnea, that provides an alternative treatment that is proven, convenient and easy to use.

X

Please login to access this valuable information. If you forgot your Username or Password, please call Metro's Client Services Team at 800.223.1600 or email service@metro-email.com (M-F, 8:45am - 5:45pm EST).